XLO - Xilio Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.00
DETAILS
HIGH:
$98.00
LOW:
$98.00
MEDIAN:
$98.00
CONSENSUS:
$98.00
UPSIDE:
1087.88%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 96.5% |
| EBIT Margin | -95.9% |
| EBITDA Margin | -92.4% |
| Operating Margin | -95.9% |
| Pretax Margin | -80.1% |
| Cont. Ops Margin | -80.1% |
| Net Margin | -80.1% |
| Bottom Line Margin | -80.1% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.58 |
| Quick Ratio | 2.58 |
| Solvency Ratio | -0.280 |
| Cash Ratio | 2.44 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-21.38
Peers avg: 13.3
|
| PEG Ratio | 0.29 |
| Forward PEG | 0.29 |
| Price/Book | 21.23 |
| Price/Sales | 17.11 |
| Price/FCF | -135.93 |
| Price/Op Cash Flow | -150.04 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0450 |
| Debt/Equity | 0.1971 |
| Debt/Capital | 0.1647 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 4.39 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.72 |
| Operating Cash Flow Ratio | -0.089 |
| Operating Cash Flow/Sales | -11.4% |
| Free Cash Flow/Operating Cash Flow | 110.4% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -30.11 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -3.72 |
| Operating Cash Flow Coverage | -0.72 |
| Capital Expenditure Coverage | -9.64 |
| Dividend + Capital Expenditure Coverage | -9.64 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.52 |
| EPS | -0.419 |
| Debt/Share | 0.0832 |
| Cash/Share | 1.65 |
| Book Value/Share | 0.42 |
| Tangible BV/Share | 0.42 |
| Equity/Share | 0.42 |
| Operating Cash Flow/Share | -0.060 |
| Capital Expenditure/Share | 0.006 |
| FCF/Share | -0.066 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.835 |
| Price/Fair Value | 21.23 |
| Debt/Market Cap | 0.0018 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -15.29 |